Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J Jr Mirro"'
Publikováno v:
Blood. 80:367-373
A monoclonal antibody (MoAb) recognizes a novel 52-Kd cell protein (MKW) that is expressed on cells of the normal myelocytic and monocytic lineage, a subset of B cells, and the U937 cell line. Using the U937 cell line as a model, the MoAb (anti-MKW)
Publikováno v:
Blood. 78:1327-1337
To define the clinical and biologic significance of childhood acute mixed-lineage leukemia diagnosed by stringent criteria, we studied 25 cases of acute lymphoblastic leukemia expressing greater than or equal to 2 myeloid-associated antigens (My+ ALL
Publikováno v:
Blood. 78:739-747
After achieving remission, approximately one-third of patients with T- cell acute lymphoblastic leukemia (T-ALL) relapse due to the resurgence of residual leukemic cells that cannot be detected in remission by morphologic methods. Thus, the early det
Autor:
H P Koeffler, R Mertelsmann, F McCormick, Lübbert M, G Isaac, G Kitchingman, Carl W. Miller, J Jr Mirro, F Herrmann, J Kahan
Publikováno v:
Blood. 75:1163-1169
Ras genes can be altered by point mutations at critical portions of their coding regions to acquire transforming ability in vitro. These point mutations have been detected in a variety of human malignancies. However, their relevance for the clinical
Publikováno v:
Blood. 76(1)
The frequency and characteristics of childhood acute leukemia with a 14q32 translocation [other than the t(8;14)(q24;q32)] were determined in 335 cases of newly diagnosed acute lymphoblastic leukemia (ALL) and 105 cases of acute nonlymphoblastic leuk
Publikováno v:
Blood. 75(1)
Frequency and clinical significance of myeloid-associated antigen expression in blast cells were assessed in 372 consecutive children with acute lymphoblastic leukemia (ALL). A comprehensive panel of myeloid monoclonal antibodies representing seven c
Autor:
GV Dahl, G Rivera, CH Pui, J Jr Mirro, J Ochs, DK Kalwinsky, M Abromowitch, AT Look, SB Murphy
Publikováno v:
Blood. 66:1110-1114
We treated 24 children and adolescents with stage III or IV lymphoblastic non-Hodgkin's lymphoma, using a protocol designed for patients with poor-prognosis acute lymphoblastic leukemia (ALL). Early therapy consisted of teniposide plus cytarabine adm
Publikováno v:
Blood. 73:1650-1655
Leukemic blast cells are thought to arise from clonal expansion of a single transformed hematopoietic cell. This generality is supported by the rarity of convincing reports on acute myeloblastic leukemia (AML) with two karyotypically independent clon